Chemoinformaics analysis of 31-Nor-Lanost-9(11)-En-3-Beta-Ol
| Molecular Weight | 398.675 | nRot | 4 |
| Heavy Atom Molecular Weight | 352.307 | nRig | 21 |
| Exact Molecular Weight | 398.355 | nRing | 4 |
| Solubility: LogS | -6.895 | nHRing | 0 |
| Solubility: LogP | 8.224 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 75 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 78.2345 |
| nHD | 1 | BPOL | 46.1475 |
| QED | 0.484 |
| Synth | 4.661 |
| Natural Product Likeliness | 3.285 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.838 |
| Pgp-sub | 0.002 |
| HIA | 0.006 |
| CACO-2 | -4.661 |
| MDCK | 0.0000108 |
| BBB | 0.223 |
| PPB | 0.96075 |
| VDSS | 3.645 |
| FU | 0.015586 |
| CYP1A2-inh | 0.163 |
| CYP1A2-sub | 0.454 |
| CYP2c19-inh | 0.104 |
| CYP2c19-sub | 0.938 |
| CYP2c9-inh | 0.217 |
| CYP2c9-sub | 0.294 |
| CYP2d6-inh | 0.079 |
| CYP2d6-sub | 0.402 |
| CYP3a4-inh | 0.683 |
| CYP3a4-sub | 0.723 |
| CL | 16.489 |
| T12 | 0.013 |
| hERG | 0.879 |
| Ames | 0.006 |
| ROA | 0.187 |
| SkinSen | 0.864 |
| Carcinogencity | 0.154 |
| EI | 0.094 |
| Respiratory | 0.889 |
| NR-Aromatase | 0.086 |
| Antiviral | No |
| Prediction | 0.657982 |